Treatment of Chronic Functional Mitral Valve Regurgitation With a Percutaneous Annuloplasty System

Journal of the American College of Cardiology

Volumn 67, Issue 25, 2016, Pages 2927-2936

  Nickenig, Georg ^a   Schueler, Robert ^a   Dager, Antonio ^b   Martinez Clark, Pedro ^b   Abizaid, Alexandre ^c   Siminiak, Tomasz ^d   Buszman, Pawel ^e   Demkow, Marcin ^f   Ebner, Adrian ^g   Asch, Federico M ^h   Hammerstingl, Christoph ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Angiographia de Occidente   (Colombia)

^c INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^d HCP Medical Center   (Poland)

^e Department of Cardiac Surgery   (Poland)

^f INSTITUTE OF CARDIOLOGY   (Poland)

^g Sanatorio Italiano   (Paraguay)

^h WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

heart failure; mitral regurgitation; percutaneous annuloplasty

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ARTICLE; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; CHRONIC FUNCTIONAL MITRAL VALVE REGURGITATION; CLINICAL PRACTICE; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEASIBILITY STUDY; FEMALE; FLUOROSCOPY; GUIDING CATHETER; HEART CATHETER; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HEART TAMPONADE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; NEW YORK HEART ASSOCIATION CLASS; PERCUTANEOUS DIRECT ANNULOPLASTY; PERCUTANEOUS DIRECT ANNULOPLASTY SYSTEM; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SIX MINUTE WALK TEST; SURGICAL EQUIPMENT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; CHRONIC DISEASE; CLINICAL TRIAL; DEVICES; MITRAL VALVE INSUFFICIENCY; TREATMENT OUTCOME;

AGED; CHRONIC DISEASE; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MITRAL VALVE ANNULOPLASTY; MITRAL VALVE INSUFFICIENCY; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84994240176     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.03.591     Document Type: Article

References (22)

1. 1 Goel, S.S., Bajaj, N., Aggarwal, B., et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol 63 (2014), 185–186.
2. 2 Iung, B., Baron, G., Butchart, E.G., et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24 (2003), 1231–1243.
3. 3 Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), e57–e185.
4. 4 Hammerstingl, C., Schueler, R., Welz, A., Nickenig, G., [Ischemic mitral regurgitation: pathomechanisms and current therapeutic options]. Internist (Berl), 54, 2013 39–7, 49.
5. 5 Kaul, S., Spotnitz, W.D., Glasheen, W.P., Touchstone, D.A., Mechanism of ischemic mitral regurgitation. An experimental evaluation. Circulation 84 (1991), 2167–2180.
6. 6 Agricola, E., Ielasi, A., Oppizzi, M., et al. Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail 11 (2009), 581–587.
7. 7 Aronson, D., Goldsher, N., Zukermann, R., et al. Ischemic mitral regurgitation and risk of heart failure after myocardial infarction. Arch Intern Med 166 (2006), 2362–2368.
8. 8 Bursi, F., Enriquez-Sarano, M., Nkomo, V.T., et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 111 (2005), 295–301.
9. 9 Enriquez-Sarano, M., Akins, C.W., Vahanian, A., Mitral regurgitation. Lancet 373 (2009), 1382–1394.
10. 10 Grigioni, F., Enriquez-Sarano, M., Zehr, K.J., et al. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103 (2001), 1759–1764.
11. 11 Crabtree, T.D., Bailey, M.S., Moon, M.R., et al. Recurrent mitral regurgitation and risk factors for early and late mortality after mitral valve repair for functional ischemic mitral regurgitation. Ann Thorac Surg 85 (2008), 1537–1542.
12. 12 Feldman, T., Kar, S., Rinaldi, M., et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 54 (2009), 686–694.
13. 13 Maisano, F., Franzen, O., Baldus, S., et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol 62 (2013), 1052–1061.
14. 14 Nickenig, G., Estevez-Loureiro, R., Franzen, O., et al. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011–2012 Pilot European Sentinel Registry. J Am Coll Cardiol 64 (2014), 875–884.
15. 15 Bolling, S.F., Pagani, F.D., Deeb, G.M., Bach, D.S., Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 115 (1998), 381–386.
16. 16 Asgar, A.W., Mack, M.J., Stone, G.W., Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol 65 (2015), 1231–1248.
17. 17 Lancellotti, P., Moura, L., Pierard, L.A., et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 11 (2010), 307–332.
18. 18 McGee, E.C., Gillinov, A.M., Blackstone, E.H., et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 128 (2004), 916–924.
19. 19 Bach, D.S., Awais, M., Gurm, H.S., Kohnstamm, S., Failure of guideline adherence for intervention in patients with severe mitral regurgitation. J Am Coll Cardiol 54 (2009), 860–865.
20. 20 Schueler, R., Ozturk, C., Wedekind, J.A., et al. Persistence of iatrogenic atrial septal defect after interventional mitral valve repair with the MitraClip system: a note of caution. J Am Coll Cardiol Intv 8 (2015), 450–459.
21. 21 Siminiak, T., Wu, J.C., Haude, M., et al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail 14 (2012), 931–938.
22. 22 Moss, A.J., Hall, W.J., Cannom, D.S., et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361 (2009), 1329–1338.